Recorded Presentation from the NCCN Pharmacy Updates: Updates on Targeted Therapy for the Treatment of Thyroid Carcinoma
Pharmacists should be aware of the new data and recommendations for targeted therapies, and how they relate to improvements in clinical efficacy and quality of life. It is also important to be aware of the potential for unique and potentially severe adverse events that can occur with these therapies.
  • Thyroid Cancer
  • Recorded Webcast
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 Participation